Nash Huw M.

CIK 00017800851 companyBEDFORD, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001780085

Recent Transactions

50 trades

Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-07-02$13.90/sh−33→ 0 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-07-02$13.10/sh−2,467→ 33 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-05-20$15.39/sh−50,000→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-05-20$0.40/sh+50,000→ 50,000 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Stock Option (Right to Buy)
2024-05-20−50,000→ 46,000 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-04-01$13.61/sh−400→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Stock Option (Right to Buy)
2024-04-01−50,000→ 96,000 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-04-01$13.22/sh−60,929→ 400 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-04-01$0.40/sh+50,000→ 61,329 total
Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2024-03-27+40,000→ 40,000 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2024-03-27+60,000→ 60,000 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-03-19$6.10/sh−4,116→ 11,329 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2024-03-15−13,100→ 39,300 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-03-15+13,100→ 15,445 total
Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Unit (RSU)
2023-12-01+8,463→ 8,463 total
Disposition to Issuer
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2023-12-01−65,600→ 0 total
Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Unit (RSU)
2023-03-15+52,400→ 52,400 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2023-03-15+78,600→ 78,600 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2022-12-07+62,000→ 62,000 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2022-03-15+107,400→ 107,400 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2022-01-03$2.19/sh+3,800→ 3,800 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2022-01-03$24.07/sh−200→ 0 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2022-01-03$22.47/sh−1,497→ 2,303 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2022-01-03$23.40/sh−2,103→ 200 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2022-01-03−3,800→ 86,822 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-12-01$25.06/sh−2,500→ 0 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-12-01$23.96/sh−3,200→ 2,500 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-12-01$2.19/sh+5,700→ 5,700 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-12-01−5,700→ 90,622 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-11-03−1,900→ 96,322 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-11-03$2.19/sh+1,900→ 1,900 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-11-03$25.00/sh−1,900→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-11-01−3,800→ 98,222 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-11-01$23.72/sh−1,610→ 0 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-11-01$23.41/sh−2,190→ 1,610 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-11-01$2.19/sh+3,800→ 3,800 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-10-01−5,700→ 102,022 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-10-01$24.83/sh−5,700→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-10-01$2.19/sh+5,700→ 5,700 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-09-01$26.00/sh−5,700→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-09-01$2.19/sh+5,700→ 5,700 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-09-01−5,700→ 107,722 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-08-02−5,700→ 113,422 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-08-02$2.19/sh+5,700→ 5,700 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-08-02$28.87/sh−5,700→ 0 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-07-01$33.33/sh−5,700→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-07-01−5,700→ 119,122 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-07-01$2.19/sh+5,700→ 5,700 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2021-06-01$39.43/sh−575→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2021-06-01−575→ 124,822 total

Companies

Stoke Therapeutics, Inc.
COO & CBO
$STOK

Recent Filings

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730

View on SEC.gov